Ovarian Cancer Staging by MDCT

authors:

avatar Mahrooz Malek 1 , *

Assistant professor of Tehran University of Medical Sciences, Tehran, Iran

how to cite: Malek M. Ovarian Cancer Staging by MDCT. Innov J Radiol. 2017;14(Special Issue):e48366. https://doi.org/10.5812/iranjradiol.48366.

Abstract

Ovarian cancer is the most lethal gynecological cancer and about 70% of the patients are advanced stagein the time of diagnosis. Decision about management (surgical debulking versus neoadjuant chemotherapy) in ovarian cancer patients is dependent on initial staging by abdominopelvic MDCT or MRI, so, Radiologist expertise on ovarian cancer staging is very important. Involvement of mesenteric root, peritoneal implante larger than 2 cm, lymphadenopathy superior to renal hilum and implants near hepatic veins are criteria for nonresectability of ovarian cancer and radiologist must be familiar and expert on the imaging protocol and findings on MDCT for ovarian cancer staging.

Full Text

Full text is available in PDF

© 2017, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.